ALVO · NASDAQ · Drug Manufacturers - Specialty & Generic

Alvotech

Develops and manufactures biosimilar medicines through an integrated platform and partner network.

$4.94
After-hours close+0.01 (+0.10%)
At close$4.94(+1.13%)
DateEstimateReportedSurprise
Nov 2026−$0.02
Aug 2026−$0.05−$0.11−109.1%
May 2026−$0.07−$0.09−28.6%
Mar 2026−$0.01−$0.37−6,334.8%
Nov 2025$0.05−$0.02−140.0%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Sep 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Sep 2020
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Mar 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 11, 2026−$0.02$136.8M
Aug 19, 2026−$0.05−$0.11−109.1%$103.0M$106.0M+2.9%
May 6, 2026−$0.07−$0.09−28.6%$112.4M$105.9M−5.8%
Mar 18, 2026−$0.01−$0.37−6,334.8%$162.2M$173.2M+6.8%
Nov 12, 2025$0.05−$0.02−140.0%$164.9M$114.0M−30.9%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Aug 13, 2025
May 7, 2025
Mar 26, 2025
Nov 13, 2024
Aug 15, 2024
May 21, 2024
Mar 20, 2024
Nov 28, 2023
Aug 30, 2023
May 19, 2023
Mar 1, 2023
Nov 16, 2022
Sep 1, 2022
May 16, 2022
Mar 30, 2022
Nov 15, 2021
Aug 16, 2021
May 20, 2021
Mar 31, 2021
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019